貴州三力(603439.SH):廣發證券等四者已合計減持1%的股份 持股降至4.8977%
格隆匯9月16日丨貴州三力(603439.SH)公佈,現公司收到股東廣發證券、廣發信德、健康基金及珠海康遠發來的《持股5%以上股東集中競價減持股份比例達1%暨減持結果吿知函》,彼等已合計減持407.33萬股,減持比例1.0000%。
此次權益變動後,廣發證券股份有限公司,廣發信德投資管理有限公司,廣州廣發信德一期健康產業投資企業(有限合夥),珠海康遠投資企業(有限合夥),四者合計持有公司股份19,949,396股,持股比例從5.8977%減少至4.8977%,不再為公司持股5%的股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.